¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"contact activation cofactor"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
cofactor
º¸Á¶ÀÎÀÚ
ristocetin cofactor
¸®½ºÅ似ƾº¸Á¶ÀÎÀÚ
activation
Ȱ¼ºÈ
activation analysis
Ȱ¼ºÈºÐ¼®, ¹æ»çȺм®
activation energy
Ȱ¼ºÈ¿¡³ÊÁö
activation factor
Ȱ¼ºÀÎÀÚ
activation gate
°³¹æ°ü¹®
activation process
Ȱ¼ºÈ°úÁ¤
complement activation
º¸Ã¼È°¼ºÈ, µµ¿òüȰ¼ºÈ
photochemical activation
±¤ÈÇÐȰ¼ºÈ
sleep activation
¼ö¸éȰ¼ºÈ
ventricular activation
½É½ÇȰ¼ºÈ
ventricular activation time
½É½ÇÈïºÐ½Ã°£
affective contact
Á¤µ¿Á¢ÃË
allergic contact dermatitis
¾Ë·¹¸£±âÁ¢ÃËÇǺο°
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
9
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
cofactor
º¸Á¶ÀÎÀÚ
activation
Ȱ¼º, Ȱ¼ºÈ, ´Éµ¿È
activation factor
Ȱ¼ºÀÎÀÚ
contact
Á¢ÃË, Á¢ÃË-
proximal contact
ÀÎÁ¢
allergic contact dermatitis
¾Ë·¹¸£±âÁ¢ÃËÇǺο°
photoallergic contact dermatitis
±¤¾Ë·¹¸£±âÁ¢ÃËÇǺο°
contact urticaria syndrome
Á¢Ã˵ε巯±âÁõÈıº
contact urticaria
Á¢Ã˵ε巯±â
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
cofactor
º¸Á¶ÀÎÀÚ
ristocetin cofactor
¸®½ºÅ似ƾº¸Á¶ÀÎÀÚ
activation
Ȱ¼º, Ȱ¼ºÈ
activation detector
Ȱ¼ºÈŽÁö±â
activation energy
Ȱ¼º¿¡³ÊÁö
activation factor
Ȱ¼ºÀÎÀÚ
activation gate
°³¹æ°ü¹®
activation process
Ȱ¼ºÈ°úÁ¤
activation analysis
Ȱ¼ºÈºÐ¼®, ¹æ»çȺм®
complement activation
µµ¿òüȰ¼º, º¸Ã¼È°¼º
photochemical activation
±¤ÈÇÐȰ¼ºÈ
sleep activation
¼ö¸éȰ¼º
ventricular activation
½É½ÇÈïºÐ
ventricular activation time
½É½ÇÈïºÐ½Ã°£
affective contact
Á¤µ¿Á¢ÃË
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
heparin cofactor II
ÇìÆÄ¸°º¸Á¶ÀÎÀÚ II
Contact lens
ÄÜÅÃÆ®·»Áî
affective contact
Á¤µ¿Àû Á¢ÃË(¡ïÈõº).
allergic contact dermatitis
¾Ë·¹¸£±â Á¢ÃËÇǺο°( ïÈõºù«Ý±æú)
allergy, contact
Á¢Ã˼º ¾Ë·¹¸£±â
arc of contact
Á¢Ã˸é, Á¢ÃËÆø
hard contact lens
ÇϵåÄÜÅÃÆ®·»Áî, °æ¼ºÄÜÅÃÆ®·»Áî
hydrogel contact lens
ÇÔ¼öÄÜÅÃÆ®·»Áî
hydrophilic contact lens
Ä£¼öÄÜÅÃÆ®·»Áî
hypersensitivity, contact
Á¢Ã˼º °ú¹Î¹ÝÀÀ
immediate contact
Á÷Á¢Àü¿°(Ì¤ËøËøËç).
indirect contact
°£Á¢Á¢ÃË.
indirect contact infection
°£Á¢Á¢Ã˰¨¿° <Àü¿°>.
inhibition, contact
Á¢Ã˼º Áõ½Ä¾ïÁ¦
proximal contact
ÀÎÁ¢(ìäïÈ).
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
cofactor
º¸Á¶ÀÎÀÚ.
cofactor
Á¶ÀÎÀÚ
heparin cofactor II
ÇìÆÄ¸°º¸Á¶ÀÎÀÚ II
ristocetin cofactor
¸®½ºÅ似ƾº¸Á¶ÀÎÀÚ(¡ÜÍð¾ì×í)
activation
Ȱ¼ºÈ
activation
Ȱ¼ºÈ(üÀàõûù).
activation analysis
¹æ»çȺм®, Ȱ¼ºÈºÐ¼®
activation analysis
Ȱ¼ºÈºÐ¼®(¡ÝÂà°), ¹æ»çÈ(Û¯ÞÒûù)ºÐ¼®.
activation detector
Ȱ¼ºÈ ŽÁö±â
activation energy
Ȱ¼ºÈ¿¡³ÊÁö
activation gate
°³¹æ °ü¹®(ËÒÛÁμڦ)
activation process
Ȱ¼ºÈ°úÁ¤.
activation, polyclonal
´Ù¼¼Æ÷±ºÈ°¼º, ¿©·¯¹«¸®È°¼º
activation, polyclonal B cell
´Ù¼¼Æ÷±º B¼¼Æ÷Ȱ¼º, ¿©·¯¹«¸® B¼¼Æ÷Ȱ¼º
c3, activation
C3, Ȱ¼º (¡üÀàõ)
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½